adenosine has been researched along with Breast Neoplasms in 100 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (7.00) | 18.7374 |
| 1990's | 4 (4.00) | 18.2507 |
| 2000's | 18 (18.00) | 29.6817 |
| 2010's | 31 (31.00) | 24.3611 |
| 2020's | 40 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ansley, K; D'Agostino, RB; Douglas, E; Hundley, WG; Jordan, JH; Kotak, A; Melin, S; O'Connell, NS; Park, S; Romitti, PA; Sorscher, S; Thomas, A; Vasu, S | 1 |
| Akgül, S; Demircan, T; Yavuz, M | 1 |
| Fan, S; Wang, L | 1 |
| Cao, L; Dong, Y; Feng, N; Huang, T; Wang, M; Xu, B | 1 |
| Chen, M; Deng, P; Liang, Y; Luo, Y; Pi, H; Tan, M; Tian, L; Wang, H; Wang, L; Xiao, H; Xie, J; Yu, Z; Yue, Y; Zhou, Z | 1 |
| Guo, H; Liu, J; Tai, J; Wang, L; Yan, Z | 1 |
| Chen, ZS; Deng, X; Hu, X; Kong, Y; Tang, H; Tang, Y; Tian, W; Tian, Z; Xie, J; Xie, X; Yan, SM; Yang, L; Ye, F; Zeng, Y; Zheng, S; Zou, Y | 1 |
| Cusmai, A; Fanizzi, A; Gadaleta-Caldarola, G; Giotta, F; Latorre, A; Lorusso, V; Massafra, R; Palmiotti, G; Rinaldi, L; Rizzo, A; Ronchi, M; Telegrafo, M; Zaccaria, GM | 1 |
| Fu, Y; Huang, X; Li, Z; Quan, Y; Tang, Q; Wang, M; Wu, A; Yang, X; Zhang, J; Zhao, P | 1 |
| Hu, S; Li, C; Ye, L; Zhang, D; Zhu, C; Zhu, Q | 1 |
| Bi, X; Cai, J; Cao, M; Chen, L; Li, K; Li, P; Wang, H; Wu, D; Xu, D; Xu, Z; Yang, J; Zheng, D | 1 |
| Klinge, CM; Petri, BJ | 1 |
| Chen, T; Li, C; Li, W; Li, Z; Wang, X; Yang, Q; Zhou, X | 1 |
| Dai, Z; Guo, L; Liu, G; Xie, F; Yuan, B; Zhang, J; Zheng, R | 1 |
| Badou, A; Benthami, H; Chraa, D; Elkarroumi, M; Karkouri, M; Olive, D; Razzouki, I; Rezouki, I; Zohair, B | 1 |
| Shi, J; Wang, H; Xu, B | 1 |
| Belal, AA; Darwish, H; Mohamed, FZ; Omran, MM; Rashed, RE | 1 |
| Sang, J; Shi, X; Wang, R; Xu, L; Yi, D; Yilihamu, Y | 1 |
| Abdellaoui, N; Barjon, C; Boissière-Michot, F; Bonnefoy, N; Chabab, G; Dejou, C; Jacot, W; Lafont, V; Lopez-Crapez, E; Michaud, HA; Pourquier, D; Salvador-Prince, L | 1 |
| Belal, A; Darwish, H; Omran, M; Rashed, R; Zahran, F | 1 |
| An, F; Chen, J; Chu, P; Cui, B; He, B; Huang, J; Lam, EW; Li, M; Li, Z; Liang, Q; Liao, Y; Liu, B; Liu, Q; Lu, J; Lv, S; Meng, Y; Peng, F; Sun, Z; Wang, F; Wang, Z; Xu, J; Xu, L; Zeng, S; Zhan, Y; Zhang, J; Zhao, H; Zou, H | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Bade, D; Dai, X; Gonzalez, G; Huang, M; Li, L; Liu, X; Miao, W; Sun, Y; Wang, Y; Yuan, J | 1 |
| Armanet, C; Cadassou, O; Chettab, K; Cros-Perrial, E; Dumontet, C; Gudefin, L; Guitton, J; Jordheim, LP; Machon, C; Raza, MZ; Tozzi, MG | 1 |
| Chang, G; Han, L; He, C; Huang, S; Huo, L; Huse, JT; Li, P; Ma, L; Ma, Y; Shi, H; Shi, L; Tiwary, S; Xie, V; Ye, Y; Zeng, L; Zhang, S; Zhu, J | 1 |
| Fan, X; Wu, G; Xiao, H; Zhang, R | 1 |
| Al-Dhabi, NA; Arasu, MV; Arockiaraj, J; Arshad, A; Charles, S; Madhavan, T; Mala, K; Munusamy-Ramanujam, G; Saraswathi, NT; Singh, P | 1 |
| Cai, J; Chen, J; Dai, R; Gao, H; Han, JJ; Lan, F; Li, Y; Ma, H; Qu, Q; Rong, B; Song, Y; Tian, Y; Wan, J; Xie, J; Xing, S; Yan, G; Zhang, L; Zhang, Q; Zhang, W | 1 |
| Ali, ES; Asara, JM; Ben-Sahra, I; Gao, P; Helmin, KA; O'Hara, BP; Sahu, U; Singer, BD; Villa, E | 1 |
| Dai, XY; Ding, Q; Huang, YZ; Li, Z; Shi, L; Wei, JF; Yang, HY; Zhang, X | 1 |
| Fang, R; Shi, H; Ye, L | 1 |
| Arévalo, B; Brown, N; Cayo, Á; García-Castillo, V; Gutiérrez, M; Olate-Briones, A; Pérez-Plasencia, C; Salgado-García, R; Valdés, F; Valenzuela, C | 1 |
| Hu, X; Huang, P; Jiang, J; Shao, Y; Xuan, Z; Yang, X; Zhang, G; Zhang, Y; Zheng, X | 1 |
| Adjei, IM; Cheng, H; Murphy, DA; Yan, X; Yang, T | 1 |
| Chen, Q; Dai, X; Li, L; Liu, X; Wang, Y; Yuan, J; Zhang, X | 1 |
| Chaim, IA; Einstein, JM; Li, H; Madrigal, AA; Meena, JK; Neill, NJ; Nussbacher, JK; Perelis, M; Shankar, A; Tankka, AT; Tyagi, S; Westbrook, TF; Yee, BA; Yeo, GW | 1 |
| Chen, Y; Ding, S; Li, Z; Liu, F; Liu, J; Wang, Y; Wei, H | 1 |
| Liu, Y; Ou, B; Xu, X; Yan, Y; Yang, X; Zhang, J | 1 |
| Huang, R; Song, Y; Tao, Y; Zhang, Q; Zheng, C | 1 |
| Buisseret, L; Craciun, L; De Caluwé, A; Eiger, D; Ignatiadis, M; Isabelle, V; Larsimont, D; Paesmans, M; Piccart, M; Poortmans, P; Reyal, F; Romano, E; Salgado, R; Sotiriou, C; Stylianos, D; Van Gestel, D; Vandekerckhove, C | 1 |
| Aghaei, M; Jafari, SM; Joshaghani, HR; Panjehpour, M; Zargar Balajam, N | 1 |
| Avan, A; Bahreyni, A; Behnam-Rassouli, R; Hassanian, SM; Khazaei, M; Parizadeh, MR; Rahmani, F; Ryzhikov, M; Samani, SS | 1 |
| Clermont, PL; Crea, F; Fornaro, L | 1 |
| Elman, JS; Gupta, PB; Jin, DX; Kuperwasser, C; Ni, TK | 1 |
| Akhavan-Niaki, H; Asouri, M; Fattahi, S; Ghadami, E; Motevalizadeh Ardekanid, A | 1 |
| Calza, S; Hwang, W; Lee, Y; Pawitan, Y; Silvestri, M | 1 |
| Chen, H; Li, X; Liang, H; Lin, Z; Niu, Y; Sun, L; Wan, A; Wan, G; Wang, Y; Wei, B; Wu, X; Xiong, XF | 1 |
| Liu, W; Ning, J; Wu, D; Wu, L; Zhang, D | 1 |
| Alcaraz, J; Baulida, J; Curto, J; Duch, P; Franco-Valls, H; García de Herreros, A; Peña, R; Sala, L; Stanisavljevic, J; Vergés, J | 1 |
| Cao, MD; Ding, Q; Gao, J; Qian, JY; Shi, L; Sun, X; Wang, S; Wei, JF; Xia, TS; Zhou, WB | 1 |
| Alvarez, AI; Espín, JC; González-Sarrías, A; Lucas, R; Merino, G; Miguel, V; Morales, JC; Tomás-Barberán, F | 1 |
| Joo, KM; Kang, W; Kim, J; Kim, SU; Kim, Y; Nam, DH; Seol, HJ; Seong, DH | 1 |
| Chen, WY; Dong, LN; Hu, M; Jiang, W; Li, Y; Liu, ZQ; Peng, XJ; Tang, L; Zeng, S | 1 |
| Fischer, B; Kafri, P; Shav-Tal, Y; Yavin, E; Zilbershtein-Shklanovsky, L | 1 |
| Ellies, LG; Gao, X; Jiang, JX; Riquelme, MA; Sun, LZ; Zhou, JZ | 1 |
| Elima, K; Härkönen, PL; Jalkanen, S; Kukkonen-Macchi, A; Vainio, M; Virtanen, SS; Yegutkin, GG | 1 |
| Chen, F; Deng, L; Mo, Q; Song, Y; Wei, L; Wu, B; Yao, Y; Zhang, L | 1 |
| Bersini, S; Charest, JL; Dubini, G; Gilardi, M; Jeon, JS; Kamm, RD; Moretti, M | 1 |
| Ambudkar, SV; Bates, SE; Di Pietro, A; Grosjean, I; Hegedus, T; Jabor Gozzi, G; Macalou, S; Robey, RW; Shukla, S | 1 |
| Dastjerdi, MN; Mardani, M; Ra, MZ; Valiani, A | 1 |
| Bao, Y; Chen, Y; Hefti, MM; Junger, WG; Ledderose, C; Li, L; Seier, T; Woehrle, T; Zhang, J | 1 |
| Chen, I; Gabrielson, E; Lu, H; Samanta, D; Semenza, GL; Zhang, C; Zhi, WI | 1 |
| Felix, R; Fernandez-Gallardo, M; González-Ramírez, R; Monjaraz, E; Sandoval, A | 1 |
| Fukami, T; Gotoh, S; Nakajima, M; Nakano, M | 1 |
| Cho, SH; Choi, MH; Chung, BC; Lee, WY | 1 |
| Cornelissen-Steijger, P; Drost, R; Evers, B; Jonkers, J; Joosse, SA; Liu, X; Nederlof, P; Pietersen, AM; Puppe, J; van Lohuizen, M; Yu, Q | 1 |
| Chan, E; Marquez, VE; Sun, F; Wu, Z; Yang, X; Yu, Q | 1 |
| Bednarek, A; Fabianowska-Majewska, K; Rudnicka, K; Stefanska, B | 1 |
| Crabb, SJ; Hayden, A; Johnson, PW; Packham, G | 1 |
| Klinkhammer, W; Pick, A; Wiese, M | 1 |
| Bednarek, A; Fabianowska-Majewska, K; Salamé, P; Stefanska, B | 1 |
| Carmona, FJ; Esteller, M; Fernandez, AF; Imai, K; Jacinto, FV; Marquez, VE; Puertas, S; Shinomura, Y; Taniguchi, H; Villanueva, A; Yamamoto, H | 1 |
| Gotoh, A; Kanno, T; Miyoshi, Y; Nakano, T; Nishizaki, T; Saito, M; Tsuchiya, A | 1 |
| Bargonetti, J; Hoffman, S; Krett, NL; Polotskaia, A; Rosen, ST; Shanmugam, M | 1 |
| Lu, J; Pierron, A; Ravid, K | 1 |
| Ayscue, LH; Jin, A; Lazarowski, E; Mitchell, BS; Ostapkowicz, A; Spychala, J | 1 |
| Karami-Tehrani, F; Panjehpour, M | 2 |
| Bennett, A; Blay, J; Hoskin, D; Mujoomdar, M | 1 |
| Ghavami, S; Hashemi, M; Karami-Tehrani, F; Los, M; Maddika, S | 1 |
| Cho, SD; Chung, H; Hong, KA; Jeong, LS; Jung, JY; Kim, H; Kim, HJ; Kim, HO; Kong, G; Lee, HW; Shin, DH | 1 |
| Gow, IF; Shennan, DB; Thomson, J | 1 |
| Chen, W; Jiang, X; Karuturi, RK; Lee, PL; Liu, ET; Tan, J; Tan, PB; Yang, X; Yu, Q; Zhuang, L | 1 |
| Chen, S; Ma, D; Ou, Z; Shao, Z; Wang, L; Yin, L; Zhi, X; Zhou, P; Zhou, T; Zhou, X | 1 |
| Alm, K; Elmroth, SK; Ghatnekar, J; Hägerlöf, M; Oredsson, S; Persson, T | 1 |
| Bullinger, D; Fehm, T; Gleiter, CH; Kammerer, B; Laufer, S; Neubauer, H | 1 |
| Bullinger, D; Frickenschmidt, A; Frohlich, H; Gleiter, CH; Kammerer, B; Laufer, S; Liebich, H; Zell, A | 1 |
| Barber, R; Butcher, RW; Goka, TJ | 1 |
| Carson, DA; Kamatani, N; Nelson-Rees, WA | 1 |
| Brooks, SC; Butler, WB; Corombos, J; Horwitz, JP; Iyer, VK; Kessel, D; Rozhin, J | 1 |
| Di Stefano, C; Liebich, HM; Schmid, HR; Wixforth, A | 1 |
| Berdel, WE; Bergmann, J; Brachwitz, H; Langen, P; Thomas, Y | 1 |
| Barry, CP; Lind, SE | 1 |
| Boyanapalli, M; Farhana, L; Fontana, JA; Hsu, CK; Rishi, AK; Sun, RJ; Tschang, SH; Zhang, YX | 1 |
| Giler, S; Kupfer, B; Moroz, C | 1 |
| Brown, PR; Hartwick, RA; Krstulović, AM | 1 |
| Dollinger, MR; Krakoff, IH | 1 |
| Fine, RL; Marangos, PJ; Montgomery, P; Morgan, PF | 1 |
| Borzenko, BG; Dumanskiĭ, IuV; Gorbachev, AA; Shepliakov, MN; Shevchenko, VV | 1 |
| Coombes, RC; Kraus, LE; Rimer, VG; Vold, BS | 1 |
5 review(s) available for adenosine and Breast Neoplasms
| Article | Year |
|---|---|
m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer.
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Breast Neoplasms; Female; Humans; Methylation; Methyltransferases; RNA; RNA-Binding Proteins; RNA, Messenger | 2023 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Understanding the roles of N
Topics: Adenosine; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Disease Progression; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Metastasis; RNA, Messenger | 2021 |
The Role of FTO in Tumors and Its Research Progress.
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Breast Neoplasms; Female; Humans; RNA, Messenger | 2022 |
Role of adenosine signaling in the pathogenesis of breast cancer.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; Inflammation; MCF-7 Cells; Neoplasm Metastasis; Receptors, Adenosine A2; Signal Transduction; Tumor Microenvironment | 2018 |
2 trial(s) available for adenosine and Breast Neoplasms
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Neo-CheckRay: radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trial.
Topics: Adenosine; Breast Neoplasms; Chemoradiotherapy; Clinical Protocols; Combined Modality Therapy; Female; Humans; Metabolic Networks and Pathways; Neoplasm Staging; Research Design | 2021 |
94 other study(ies) available for adenosine and Breast Neoplasms
| Article | Year |
|---|---|
Myocardial Function in Premenopausal Women Treated With Ovarian Function Suppression and an Aromatase Inhibitor.
Topics: Adenosine; Adult; Age Factors; Aromatase Inhibitors; Body Mass Index; Breast Neoplasms; Cardiotoxicity; Female; Humans; Magnetic Resonance Imaging; Microcirculation; Middle Aged; Ovary; Pilot Projects; Premenopause; Receptors, Estrogen; Stroke Volume; Triple Negative Breast Neoplasms; Ventricular Function, Left | 2021 |
m
Topics: Adenosine; Animals; Breast Neoplasms; Carcinoma; Female; Gene Expression Regulation, Neoplastic; Humans; RNA, Messenger | 2021 |
N
Topics: Adenosine; Base Sequence; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Methyltransferases; MicroRNAs; Middle Aged; Prognosis; RNA, Long Noncoding | 2021 |
N
Topics: 3' Untranslated Regions; Adenosine; Animals; Breast; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Male; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; RNA Splicing Factors; RNA, Long Noncoding; SAP90-PSD95 Associated Proteins; Up-Regulation | 2021 |
N6-methyladenosine-mediated downregulation of miR-374c-5p promotes cadmium-induced cell proliferation and metastasis by targeting GRM3 in breast cancer cells.
Topics: Adenosine; Breast Neoplasms; Cadmium; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs | 2022 |
Prognostic implications of N
Topics: Adenosine; Breast Neoplasms; Carcinoma; Case-Control Studies; Humans; Lymphocytes, Tumor-Infiltrating; Molecular Targeted Therapy; Prognosis; RNA; RNA-Binding Proteins; Tumor Microenvironment | 2022 |
N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer.
Topics: Adenosine; beta Catenin; Breast Neoplasms; Cell Death; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Glycogen Synthase Kinase 3 beta; Humans; Iron; Receptor, ErbB-2; Receptor, Fibroblast Growth Factor, Type 4 | 2022 |
Adenosine pathway inhibitors: novel investigational agents for the treatment of metastatic breast cancer.
Topics: Adenosine; Adenosine Triphosphate; Apoptosis; Breast Neoplasms; Female; Humans; Immunotherapy | 2022 |
Bioinformatics Analysis of the Characteristics and Correlation of m6A Methylation in Breast Cancer Progression.
Topics: Adenosine; Breast Neoplasms; Computational Biology; Female; Humans; Methylation; RNA | 2022 |
Comprehensive Analysis of the Expression and Prognostic Value of LMAN2 in HER2+ Breast Cancer.
Topics: Adenosine; Breast Neoplasms; Female; Humans; Mannose-Binding Lectins; Membrane Transport Proteins; Methylation; Prognosis | 2022 |
Identification and functional analysis of N6-methyladenine (m
Topics: Adenosine; Breast Neoplasms; Carcinogenesis; Cell Transformation, Neoplastic; Female; Humans; RNA, Long Noncoding | 2023 |
Identification and validation of an m6A-related gene signature to predict prognosis and evaluate immune features of breast cancer.
Topics: Adenosine; Algorithms; Breast Neoplasms; Carcinogenesis; Female; Humans; Reproducibility of Results; Tumor Microenvironment | 2023 |
Novel RNA N6-methyladenosine regulator related signature for predicting clinical and immunological characteristics in breast cancer.
Topics: Adenosine; Breast; Breast Neoplasms; Epigenomics; Female; Humans; Tumor Microenvironment | 2023 |
The immune checkpoint adenosine 2A receptor is associated with aggressive clinical outcomes and reflects an immunosuppressive tumor microenvironment in human breast cancer.
Topics: Adenosine; Algorithms; Animals; Breast Neoplasms; Female; Humans; Mammary Neoplasms, Animal; Tumor Microenvironment | 2023 |
N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2.
Topics: Adenosine; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Progression; Female; Humans; Methyltransferases; Proto-Oncogene Proteins c-bcl-2 | 2020 |
Development of a gas chromatography-mass spectrometry method for breast cancer diagnosis based on nucleoside metabolomes 1-methyl adenosine, 1-methylguanosine and 8-hydroxy-2'-deoxyguanosine.
Topics: Adenosine; Adult; Aged; Breast Neoplasms; Female; Gas Chromatography-Mass Spectrometry; Guanosine; Humans; Limit of Detection; Linear Models; Metabolome; Metabolomics; Middle Aged; Reproducibility of Results | 2020 |
METTL14 promotes the migration and invasion of breast cancer cells by modulating N6‑methyladenosine and hsa‑miR‑146a‑5p expression.
Topics: Adenosine; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Methyltransferases; MicroRNAs; Neoplasm Invasiveness; Up-Regulation | 2020 |
Identification of a regulatory Vδ1 gamma delta T cell subpopulation expressing CD73 in human breast cancer.
Topics: 5'-Nucleotidase; Adenosine; Adolescent; Adult; Aged; Breast Neoplasms; Case-Control Studies; Cell Differentiation; Cell Lineage; Female; Gene Expression Regulation, Neoplastic; GPI-Linked Proteins; Humans; Interleukin-10; Interleukin-8; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Middle Aged; Primary Cell Culture; Receptors, Antigen, T-Cell, alpha-beta; Receptors, Antigen, T-Cell, gamma-delta; Signal Transduction; T-Lymphocytes, Regulatory; Tumor Microenvironment | 2020 |
A novel serum metabolome score for breast cancer diagnosis.
Topics: Adenosine; Adult; Biomarkers, Tumor; Breast Neoplasms; Case-Control Studies; Deoxyguanosine; Early Detection of Cancer; Female; Guanosine; Humans; Metabolome; Middle Aged; Mucin-1; ROC Curve; Sensitivity and Specificity | 2020 |
Oncogenic AURKA-enhanced N
Topics: Adenosine; Adult; Aged; Animals; Aurora Kinase A; Breast Neoplasms; Female; Glycoproteins; HEK293 Cells; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Neoplastic Stem Cells; Oncogene Proteins; Ribonuclease III; RNA Stability; Signal Transduction; Transcriptional Activation; Transfection; Tumor Burden; Xenograft Model Antitumor Assays | 2021 |
Adenylate Kinase 4 Modulates the Resistance of Breast Cancer Cells to Tamoxifen through an m
Topics: Adenosine; Adenylate Kinase; Antineoplastic Agents, Hormonal; Apoptosis; Breast Neoplasms; Cell Proliferation; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; MCF-7 Cells; Methylation; Methyltransferases; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Tamoxifen; Transfection | 2020 |
Enhanced migration of breast and lung cancer cells deficient for cN-II and CD73 via COX-2/PGE2/AKT axis regulation.
Topics: 5'-Nucleotidase; Adenosine; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cyclooxygenase 2; Dinoprostone; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Models, Biological; Nucleotides; Proto-Oncogene Proteins c-akt; RNA, Messenger; Signal Transduction | 2021 |
YTHDF3 Induces the Translation of m
Topics: 5' Untranslated Regions; Adenosine; Animals; Brain Neoplasms; Breast Neoplasms; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Mice; Neoplasm Transplantation; RNA-Binding Proteins; Survival Analysis; Up-Regulation | 2020 |
Upregulated N6-Methyladenosine RNA in Peripheral Blood: Potential Diagnostic Biomarker for Breast Cancer.
Topics: Adenosine; Biomarkers, Tumor; Breast Neoplasms; Female; Humans; Middle Aged; Prognosis; RNA; Up-Regulation | 2021 |
Pharmacologic downregulation of protein arginine methyltransferase1 expression by adenosine dialdehyde increases cell senescence in breast cancer.
Topics: Adenosine; Antineoplastic Combined Chemotherapy Protocols; Arginine; Betaine-Homocysteine S-Methyltransferase; Breast Neoplasms; Cell Cycle Checkpoints; Cell Proliferation; Cellular Senescence; Down-Regulation; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Methylation; Molecular Docking Simulation; Oxidative Stress; Phosphatidylethanolamine N-Methyltransferase; Protein Processing, Post-Translational; Protein-Arginine N-Methyltransferases; Repressor Proteins; Signal Transduction; Tamoxifen | 2021 |
Ribosome 18S m
Topics: Adenosine; Animals; Breast Neoplasms; Caenorhabditis elegans; Cell Growth Processes; Cell Line, Tumor; Female; HEK293 Cells; HeLa Cells; Humans; MCF-7 Cells; Methylation; Methyltransferases; RNA, Ribosomal, 18S | 2020 |
mTORC1 stimulates cell growth through SAM synthesis and m
Topics: Adenosine; Animals; Base Sequence; Breast Neoplasms; Cell Cycle Proteins; Cell Proliferation; Female; HEK293 Cells; HeLa Cells; Humans; Mechanistic Target of Rapamycin Complex 1; Methionine Adenosyltransferase; Methylation; Mice, Nude; Protein Biosynthesis; Proto-Oncogene Proteins c-myc; RNA Splicing Factors; RNA, Messenger; S-Adenosylmethionine; Signal Transduction; Transcription, Genetic | 2021 |
CircMETTL3, upregulated in a m6A-dependent manner, promotes breast cancer progression.
Topics: Adenosine; Breast Neoplasms; Carcinogenesis; CDC2 Protein Kinase; Cell Movement; Cell Proliferation; Disease Progression; Drug Discovery; Gene Expression Regulation, Neoplastic; Humans; Methyltransferases; MicroRNAs; Neoplasm Invasiveness; RNA, Circular; Signal Transduction | 2021 |
Two New Adenosine Derivatives and their Antiproliferative Properties: An
Topics: Adenosine; Apoptosis; Breast Neoplasms; Cell Cycle; Female; Humans; Receptor, Adenosine A3 | 2022 |
Integrative genomic analysis of N6-methyladenosine-single nucleotide polymorphisms (m
Topics: Adaptor Proteins, Signal Transducing; Adenosine; Base Sequence; Breast Neoplasms; Case-Control Studies; Databases, Genetic; Female; Gene Ontology; Genetic Predisposition to Disease; Genomics; Humans; MafF Transcription Factor; Nuclear Proteins; Polymorphism, Single Nucleotide; Quantitative Trait Loci | 2021 |
Reversing Hypoxia with PLGA-Encapsulated Manganese Dioxide Nanoparticles Improves Natural Killer Cell Response to Tumor Spheroids.
Topics: Adaptive Immunity; Adenosine; Adoptive Transfer; Breast Neoplasms; Cell Hypoxia; Female; Humans; Hydrogen Peroxide; Immune Tolerance; Killer Cells, Natural; Lactic Acid; Manganese Compounds; MCF-7 Cells; Metal Nanoparticles; Nanocapsules; Oxides; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer; Signal Transduction; Spheroids, Cellular; Tumor Microenvironment | 2021 |
ATF3 Modulates the Resistance of Breast Cancer Cells to Tamoxifen through an
Topics: Activating Transcription Factor 3; Adenosine; Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug Resistance, Neoplasm; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; RNA, Messenger; Tamoxifen | 2021 |
Inhibition of YTHDF2 triggers proteotoxic cell death in MYC-driven breast cancer.
Topics: Adenosine; Animals; Breast Neoplasms; Cell Death; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Genes, myc; Humans; Mice, Nude; Mice, Transgenic; Protein Biosynthesis; RNA-Binding Proteins; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2021 |
C5aR1-positive neutrophils promote breast cancer glycolysis through WTAP-dependent m6A methylation of ENO1.
Topics: Adenosine; Animals; Biomarkers, Tumor; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Disease Progression; DNA-Binding Proteins; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Male; Metabolome; Methylation; Mice, Inbred BALB C; Mice, Nude; Models, Biological; Neutrophils; Phosphopyruvate Hydratase; Phosphorylation; Principal Component Analysis; Promoter Regions, Genetic; Protein Stability; Receptor, Anaphylatoxin C5a; RNA Splicing Factors; Signal Transduction; Stochastic Processes; Survival Analysis; Tumor Suppressor Proteins; Up-Regulation | 2021 |
N6-Methyladenosine Regulators Are Involved in the Progression of and Have Clinical Impact on Breast Cancer.
Topics: Adenosine; Breast Neoplasms; Cell Cycle Proteins; Cell Differentiation; Drug Resistance, Neoplasm; Female; Gene Regulatory Networks; Humans; Methyltransferases; Neoplasm Staging; Predictive Value of Tests; Prognosis; Protein Interaction Maps; Risk Assessment; RNA Splicing Factors; RNA-Binding Proteins | 2021 |
Apoptosis and cell cycle regulatory effects of adenosine by modulation of GLI-1 and ERK1/2 pathways in CD44
Topics: Adenosine; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Caspase 6; CD24 Antigen; Cell Line, Tumor; Cyclin D1; Cyclin-Dependent Kinase 4; Down-Regulation; Female; G1 Phase Cell Cycle Checkpoints; Humans; Hyaluronan Receptors; MAP Kinase Signaling System; MCF-7 Cells; Membrane Potential, Mitochondrial; Neoplastic Stem Cells; Proto-Oncogene Proteins c-bcl-2; Zinc Finger Protein GLI1 | 2017 |
Elevated expression of a pharmacologic Polycomb signature predicts poor prognosis in gastric and breast cancer.
Topics: Adenosine; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Male; Polycomb-Group Proteins; Stomach Neoplasms; Survival Analysis; Up-Regulation | 2017 |
Premature polyadenylation of MAGI3 is associated with diminished N
Topics: Adenosine; BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; Exons; Female; Gene Expression Regulation, Neoplastic; Humans; Introns; Membrane Proteins; Polyadenylation; Protein Serine-Threonine Kinases; RNA, Messenger; Up-Regulation | 2018 |
Urtica dioica inhibits cell growth and induces apoptosis by targeting Ornithine decarboxylase and Adenosine deaminase as key regulatory enzymes in adenosine and polyamines homeostasis in human breast cancer cell lines.
Topics: Adenosine; Adenosine Deaminase; Adenosine Deaminase Inhibitors; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Proliferation; Female; Humans; MCF-7 Cells; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Plant Extracts; Polyamines; Urtica dioica | 2018 |
CREDO: Highly confident disease-relevant A-to-I RNA-editing discovery in breast cancer.
Topics: Adenosine; Breast Neoplasms; Computational Biology; Databases, Genetic; Exome Sequencing; Female; Humans; Inosine; Kaplan-Meier Estimate; RNA Editing; Web Browser | 2019 |
RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Case-Control Studies; Cell Movement; Cell Proliferation; Demethylation; Disease Progression; Epigenesis, Genetic; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Neoplasm Invasiveness; Prognosis; Proto-Oncogene Proteins; Survival Rate; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |
Changes of N6-methyladenosine modulators promote breast cancer progression.
Topics: Adenosine; Adult; Breast; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Datasets as Topic; Disease Progression; Epigenesis, Genetic; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Methylation; Methyltransferases; Middle Aged; Mutation; Oxidoreductases, N-Demethylating; Prognosis; RNA, Messenger | 2019 |
Abrogation of myofibroblast activities in metastasis and fibrosis by methyltransferase inhibition.
Topics: Adenosine; Animals; Breast Neoplasms; Cancer-Associated Fibroblasts; Cell Line, Tumor; Cell Transdifferentiation; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Epigenesis, Genetic; Female; Gene Deletion; Humans; Idiopathic Pulmonary Fibrosis; Lung Neoplasms; Methyltransferases; Mice; Myofibroblasts; Snail Family Transcription Factors; Transforming Growth Factor beta; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2019 |
KIAA1429 acts as an oncogenic factor in breast cancer by regulating CDK1 in an N6-methyladenosine-independent manner.
Topics: Adenosine; Animals; Breast Neoplasms; Carcinogenesis; CDC2 Protein Kinase; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Mice; Mice, Nude; Oncogenes; RNA-Binding Proteins; Tumor Cells, Cultured | 2019 |
The gut microbiota ellagic acid-derived metabolite urolithin A and its sulfate conjugate are substrates for the drug efflux transporter breast cancer resistance protein (ABCG2/BCRP).
Topics: Adenosine; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Cattle; Cell Line, Tumor; Coumarins; Diketopiperazines; Dogs; Ellagic Acid; Female; Glucuronides; Heterocyclic Compounds, 4 or More Rings; Humans; Hydrolyzable Tannins; Madin Darby Canine Kidney Cells; Mice; Microbiota; Mitoxantrone; Neoplasm Proteins; Sheep; Sulfates | 2013 |
Adenosine potentiates the therapeutic effects of neural stem cells expressing cytosine deaminase against metastatic brain tumors.
Topics: Adenosine; Animals; Antimetabolites, Antineoplastic; Apoptosis; Blood-Brain Barrier; Blotting, Western; Brain Neoplasms; Breast Neoplasms; Cell Proliferation; Cells, Cultured; Cytosine Deaminase; Drug Synergism; Female; Fetus; Flucytosine; Fluorouracil; Genetic Engineering; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neural Stem Cells; Prodrugs; Vasodilator Agents; Xenograft Model Antitumor Assays | 2013 |
Breast cancer resistance protein-mediated efflux of luteolin glucuronides in HeLa cells overexpressing UDP-glucuronosyltransferase 1A9.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Diketopiperazines; Dose-Response Relationship, Drug; Female; Glucuronides; Glucuronosyltransferase; HeLa Cells; Heterocyclic Compounds, 4 or More Rings; Humans; Luteolin; Neoplasm Proteins; UDP-Glucuronosyltransferase 1A9 | 2014 |
Development of fluorescent double-strand probes labeled with 8-(p-CF3-cinnamyl)-adenosine for the detection of cyclin D1 breast cancer marker.
Topics: Adenosine; Biomarkers, Tumor; Breast Neoplasms; Cinnamates; Cyclin D1; Female; Fluorescent Dyes; Humans; Kinetics; Temperature; Tumor Cells, Cultured | 2014 |
Differential impact of adenosine nucleotides released by osteocytes on breast cancer growth and bone metastasis.
Topics: Adenosine; Adenosine Triphosphate; Alendronate; Animals; Apyrase; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Humans; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Osteocytes; Receptor, Adenosine A2A; Receptors, Purinergic P2X; RNA Interference; RNA, Small Interfering; Signal Transduction; Transplantation, Heterologous | 2015 |
Adenosine inhibits tumor cell invasion via receptor-independent mechanisms.
Topics: Adenosine; Antineoplastic Agents; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Neoplasm Invasiveness; Prostatic Neoplasms; Purinergic P1 Receptor Agonists; Receptors, Purinergic P1; Signal Transduction | 2014 |
Inhibition of histone H3K79 methylation selectively inhibits proliferation, self-renewal and metastatic potential of breast cancer.
Topics: Adenosine; Animals; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Differentiation; Cell Movement; Cell Proliferation; DNA Methylation; Enzyme Inhibitors; Female; Flow Cytometry; Histone-Lysine N-Methyltransferase; Histones; Humans; Immunoenzyme Techniques; Lysine; Methyltransferases; Mice; Mice, Nude; Neoplastic Stem Cells; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2014 |
Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation.
Topics: Adenosine; Animals; Breast Neoplasms; Capillary Permeability; Cell Line, Tumor; Cellular Microenvironment; Extravasation of Diagnostic and Therapeutic Materials; Female; Human Umbilical Vein Endothelial Cells; Humans; Mice; Microfluidics; Microvessels; Shear Strength; Stress, Mechanical | 2015 |
The linker region of breast cancer resistance protein ABCG2 is critical for coupling of ATP-dependent drug transport.
Topics: Adenosine; Adenosine Triphosphatases; Adenosine Triphosphate; Amino Acid Sequence; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Cell Proliferation; Cell Survival; Diketopiperazines; Drug Resistance, Neoplasm; Female; HEK293 Cells; Heterocyclic Compounds, 4 or More Rings; Humans; Mitoxantrone; Molecular Sequence Data; Mutagenesis, Site-Directed; Neoplasm Proteins; Sequence Alignment | 2016 |
Adenosine A1 receptor modifies P53 expression and apoptosis in breast cancer cell line Mcf-7.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Apoptosis; Breast Neoplasms; Cell Proliferation; Cell Survival; Gene Expression Profiling; Genes, p53; Humans; MCF-7 Cells; Receptor, Adenosine A1; Xanthines | 2016 |
Adenosine arrests breast cancer cell motility by A3 receptor stimulation.
Topics: Adenosine; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Female; Humans; Purinergic P1 Receptor Agonists; Receptor, Adenosine A3; Signal Transduction | 2016 |
Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells.
Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; Animals; Breast Neoplasms; Cell Hypoxia; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; MCF-7 Cells; Methylation; Mice; Mice, SCID; Nanog Homeobox Protein; Neoplastic Stem Cells; RNA, Messenger; RNA, Small Interfering; Trans-Activators; Xenograft Model Antitumor Assays | 2016 |
Adenosine Stimulate Proliferation and Migration in Triple Negative Breast Cancer Cells.
Topics: Adenosine; Adenylyl Cyclases; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Female; Humans; NAV1.5 Voltage-Gated Sodium Channel; Neoplasm Proteins; Receptor, Adenosine A2B; Second Messenger Systems | 2016 |
A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer.
Topics: 3' Untranslated Regions; Adenosine; Adenosine Deaminase; Breast; Breast Neoplasms; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Inosine; MCF-7 Cells; MicroRNAs; RNA Editing; RNA-Binding Proteins; Tetrahydrofolate Dehydrogenase; Up-Regulation | 2017 |
Evaluation of urinary nucleosides in breast cancer patients before and after tumor removal.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adenosine; Adult; Breast Neoplasms; Chromatography, Liquid; Deoxyguanosine; Female; Guanosine; Humans; Mastectomy; Middle Aged; Nucleosides; Oxidative Stress; Postoperative Period; Reactive Oxygen Species; Tandem Mass Spectrometry; Thymidine | 2009 |
BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A.
Topics: Adenosine; Animals; BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; DNA Repair; Drug Delivery Systems; Enhancer of Zeste Homolog 2 Protein; Female; Gene Knockdown Techniques; Genes, BRCA1; Histone-Lysine N-Methyltransferase; Humans; Mice; Mutation; Polycomb Repressive Complex 2; Recombinant Fusion Proteins; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering | 2009 |
Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells.
Topics: Adenosine; Antigens, Neoplasm; Azacitidine; Breast Neoplasms; Cell Line; Cell Line, Tumor; Chromatin Immunoprecipitation; Cluster Analysis; CpG Islands; Decitabine; DNA Methylation; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Immunoblotting; Methylation; Neoplasm Proteins; Oligonucleotide Array Sequence Analysis; Polycomb Repressive Complex 2; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Transcription Factors | 2009 |
Hypomethylation and induction of retinoic acid receptor beta 2 by concurrent action of adenosine analogues and natural compounds in breast cancer cells.
Topics: Adenosine; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cholecalciferol; Cladribine; DNA Methylation; Drug Screening Assays, Antitumor; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Promoter Regions, Genetic; Receptors, Retinoic Acid; Resveratrol; Stilbenes; Transcriptional Activation; Tretinoin; Vidarabine | 2010 |
S-adenosylhomocysteine hydrolase inhibition by 3-deazaneplanocin A analogues induces anti-cancer effects in breast cancer cell lines and synergy with both histone deacetylase and HER2 inhibition.
Topics: Adenosine; Adenosylhomocysteinase; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cytoplasm; Drug Synergism; Female; Histone Deacetylase Inhibitors; Humans; Lipid Metabolism; Protein Kinase Inhibitors; Receptor, ErbB-2 | 2011 |
Specific inhibitors of the breast cancer resistance protein (BCRP).
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Binding Sites; Breast Neoplasms; Cell Line, Tumor; Chlorophyll; Diketopiperazines; Drug Resistance, Multiple; Female; Heterocyclic Compounds, 4 or More Rings; Humans; Imatinib Mesylate; Indoles; Neoplasm Proteins; Novobiocin; Piperazines; Pyrimidines; Quinolines; Structure-Activity Relationship | 2010 |
Comparative effects of retinoic acid, vitamin D and resveratrol alone and in combination with adenosine analogues on methylation and expression of phosphatase and tensin homologue tumour suppressor gene in breast cancer cells.
Topics: Adenocarcinoma; Adenosine; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antioxidants; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cholecalciferol; Cyclin-Dependent Kinase Inhibitor p21; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Neoplasm Proteins; Promoter Regions, Genetic; PTEN Phosphohydrolase; Resveratrol; RNA, Messenger; Stilbenes; Tretinoin; Vitamins | 2012 |
Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer.
Topics: Adenosine; Animals; Breast Neoplasms; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Female; Humans; Kruppel-Like Transcription Factors; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Polycomb Repressive Complex 2; Prostatic Neoplasms; RNA Interference; Transcription Factors; Transfection | 2012 |
Intracellularly transported adenosine induces apoptosis in [corrected] MCF-7 human breast cancer cells by accumulating AMID in the nucleus.
Topics: Adenosine; Apoptosis; Apoptosis Regulatory Proteins; Biological Transport; Breast Neoplasms; Cell Line, Tumor; Cell Nucleus; Female; Gene Knockdown Techniques; Humans; Mitochondrial Proteins; Signal Transduction | 2012 |
8-Amino-adenosine activates p53-independent cell death of metastatic breast cancers.
Topics: Adenosine; Antineoplastic Agents; Autophagy; Breast Neoplasms; Caspase Inhibitors; Cell Death; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Doxycycline; Female; Humans; Mutant Proteins; Neoplasm Metastasis; Oligopeptides; Receptors, Estrogen; Signal Transduction; Transcription, Genetic; Tumor Suppressor Protein p53 | 2012 |
An adenosine analogue, IB-MECA, down-regulates estrogen receptor alpha and suppresses human breast cancer cell proliferation.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Apoptosis; Breast Neoplasms; Cell Adhesion; Cell Division; Cell Line, Tumor; Down-Regulation; Estrogen Receptor alpha; G1 Phase; Gene Expression Regulation, Neoplastic; Humans; Receptors, Estrogen; S Phase; Signal Transduction; Transcription, Genetic | 2003 |
Role of estrogen receptor in the regulation of ecto-5'-nucleotidase and adenosine in breast cancer.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Deaminase; Adenosine Monophosphate; Adenosine Triphosphate; Blotting, Northern; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Chromatography, High Pressure Liquid; Disease Progression; Estradiol; Estrogens; Gene Expression Regulation, Neoplastic; Genes, Dominant; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Phorbol Esters; Plasmids; Receptors, Estrogen; RNA, Messenger; Time Factors; Transfection | 2004 |
An adenosine analog (IB-MECA) inhibits anchorage-dependent cell growth of various human breast cancer cell lines.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Colforsin; Cyclic AMP; Female; Gene Expression Regulation, Neoplastic; Humans; Receptor, Adenosine A3; Signal Transduction | 2004 |
Adenosine stimulation of proliferation of breast carcinoma cell lines: evaluation of the [3H]thymidine assay system and modulatory effects of the cellular microenvironment in vitro.
Topics: Adenosine; Breast Neoplasms; Cell Count; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Culture Media, Conditioned; DNA; DNA Replication; Dose-Response Relationship, Drug; Humans; Serum; Thymidine; Tritium | 2004 |
Adenosine and deoxyadenosine induces apoptosis in oestrogen receptor-positive and -negative human breast cancer cells via the intrinsic pathway.
Topics: Adenine; Adenosine; Apoptosis; Breast Neoplasms; Caspase 3; Caspase 9; Caspases; Cell Line, Tumor; Cell Proliferation; Deoxyadenosines; Dose-Response Relationship, Drug; Humans; Receptors, Estrogen; Thioinosine; Time Factors | 2005 |
The antitumor effect of LJ-529, a novel agonist to A3 adenosine receptor, in both estrogen receptor-positive and estrogen receptor-negative human breast cancers.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspase 3; Caspases; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p27; Down-Regulation; Estrogen Receptor alpha; Humans; Mice; Poly(ADP-ribose) Polymerases; Receptor, ErbB-2; Signal Transduction; Thionucleosides; Wnt Proteins; Xenograft Model Antitumor Assays | 2006 |
Osmoregulation of taurine efflux from cultured human breast cancer cells: comparison with volume activated Cl- efflux and regulation by extracellular ATP.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Adenosine; Adenosine Triphosphate; Biological Transport; Breast Neoplasms; Cell Line, Tumor; Chloride Channels; Chlorides; Dose-Response Relationship, Drug; Female; Humans; Iodides; Ionomycin; Osmolar Concentration; Suramin; Taurine; Time Factors | 2006 |
Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells.
Topics: Adenosine; Adenosylhomocysteinase; Apoptosis; Base Sequence; Breast Neoplasms; Cell Line, Tumor; Chromatin Assembly and Disassembly; Chromatin Immunoprecipitation; Enzyme Inhibitors; Epigenesis, Genetic; Female; Histones; Humans; Methylation; Polycomb-Group Proteins; Promoter Regions, Genetic; Repressor Proteins; RNA Interference; RNA Polymerase II; RNA, Small Interfering | 2007 |
Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Breast Neoplasms; Cell Adhesion; Cell Movement; Extracellular Matrix; Female; Humans; Neoplasm Invasiveness; Transfection | 2008 |
Construction of polyamine-modified uridine and adenosine derivatives--evaluation of DNA binding capacity and cytotoxicity in vitro.
Topics: Adenosine; Binding Sites; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Circular Dichroism; DNA; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; In Vitro Techniques; Molecular Structure; Polyamines; Structure-Activity Relationship; Temperature; Tumor Cells, Cultured; Uridine | 2007 |
Metabolic signature of breast cancer cell line MCF-7: profiling of modified nucleosides via LC-IT MS coupling.
Topics: Adenosine; Aminoimidazole Carboxamide; Biomarkers, Tumor; Breast Neoplasms; Cell Line; Cell Line, Tumor; Epithelial Cells; Female; Guanosine; Humans; Imidazoles; Ions; Mammary Glands, Human; Metabolic Networks and Pathways; Ribonucleosides; Ribose; S-Adenosylmethionine; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Uridine | 2007 |
Adenosine modulates cell growth in the human breast cancer cells via adenosine receptors.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Adenylyl Cyclases; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cyclic AMP; Female; Gene Expression Regulation; Humans; Receptor, Adenosine A2B; Receptor, Adenosine A3; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
Metabonomics in cancer diagnosis: mass spectrometry-based profiling of urinary nucleosides from breast cancer patients.
Topics: Adenosine; Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Artificial Intelligence; Biomarkers; Breast Neoplasms; Cytidine; False Negative Reactions; False Positive Reactions; Female; Guanosine; Humans; Inosine; Mass Spectrometry; Middle Aged; Nucleosides; Principal Component Analysis; Reproducibility of Results; Sensitivity and Specificity; Uridine | 2008 |
Hormone and methylxanthine action on breast epithelial cells.
Topics: 2-Chloroadenosine; Adenosine; Animals; Breast; Breast Neoplasms; Caffeine; Cell Line; Cyclic AMP; Epithelium; Female; Fibrocystic Breast Disease; Humans; Mice; Terbutaline; Xanthines | 1984 |
Selective killing of human malignant cell lines deficient in methylthioadenosine phosphorylase, a purine metabolic enzyme.
Topics: Adenosine; Azaserine; Breast Neoplasms; Cell Line; Cell Survival; Humans; Leukemia; Melanoma; Methotrexate; Neoplasms; Pentosyltransferases; Purine-Nucleoside Phosphorylase; Thionucleosides | 1981 |
Some adenine and adenosine methylene-bridged estrogens.
Topics: Adenine; Adenosine; Animals; Breast Neoplasms; Cell Line; Drug Evaluation, Preclinical; Estradiol Congeners; Female; Humans; Indicators and Reagents; Leukemia P388; Mice; Structure-Activity Relationship | 1983 |
Quantitation of urinary nucleosides by high-performance liquid chromatography.
Topics: Adenosine; Breast Neoplasms; Chromatography, High Pressure Liquid; Deoxyadenosines; Female; Guanosine; Humans; Male; Mouth Neoplasms; Nucleosides; Pseudouridine; Ribonucleosides; Thionucleosides | 1997 |
New nucleoside-5'-alkylphosphonophosphates and related compounds containing 2'-deoxycytidine, thymidine and adenosine as nucleoside component. Syntheses and their effects on tumor cell growth in vitro.
Topics: Adenosine; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Division; Chromatography, Thin Layer; Deoxycytidine; Female; Humans; Mass Spectrometry; Molecular Structure; Nucleotides; Organophosphorus Compounds; Phospholipids; Thymidine; Tumor Cells, Cultured | 1997 |
Adenosine-mediated killing of cultured epithelial cancer cells.
Topics: Adenine; Adenosine; Adenosine Deaminase Inhibitors; Adenosine Kinase; Apoptosis; Breast Neoplasms; Carcinoma, Squamous Cell; Cell Division; Cell Survival; Coformycin; Deoxyadenosines; Dipyridamole; Enzyme Inhibitors; Female; Humans; Kinetics; Ovarian Neoplasms; Pentostatin; Tumor Cells, Cultured | 2000 |
Okadaic acid-mediated induction of the c-fos gene in estrogen receptor-negative human breast carcinoma cells utilized, in part, posttranscriptional mechanisms involving adenosine-uridine-rich elements.
Topics: Adenosine; Breast Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Genes, fos; Genes, myc; Humans; Okadaic Acid; Phosphoprotein Phosphatases; Receptors, Estrogen; RNA Processing, Post-Transcriptional; Signal Transduction; Tumor Cells, Cultured; Uridine | 2000 |
Circulating human T cell subset with a reversible E-rossetting capacity in cancer and normals-hypothesis on the regulatory mechanism influencing their role in CMI.
Topics: Adenosine; Breast Neoplasms; Classification; Ferritins; Hodgkin Disease; Humans; Immunity, Cellular; Levamisole; Rosette Formation; T-Lymphocytes | 1979 |
Selective analysis of adenosine, 1-methylinosine and N2-methylguanosine by high pressure liquid chromatography.
Topics: Adenosine; Adenosine Deaminase; Breast Neoplasms; Chromatography, High Pressure Liquid; Female; Guanosine; Humans; Inosine | 1978 |
Hemolysis induced by 6-N-hydroxylaminopurine riboside, an adenosine analogue.
Topics: Adenosine; Adult; Bilirubin; Blood Cell Count; Breast Neoplasms; Dipyridamole; Erythrocytes; Female; Hemoglobins; Hemolysis; Humans; Hydroxylamines; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasms; Purines; Rectal Neoplasms; Reticulocytes; Time Factors | 1975 |
Multidrug resistance in MCF-7 human breast cancer cells is associated with increased expression of nucleoside transporters and altered uptake of adenosine.
Topics: Adenosine; Breast Neoplasms; Carrier Proteins; Doxorubicin; Drug Resistance; Humans; Membrane Proteins; Nucleoside Transport Proteins; Phenotype; Protein Kinase C; Tumor Cells, Cultured; Vinblastine; Vincristine | 1991 |
[Activity of the enzymes of DNA metabolism in the blood of patients with breast cancer].
Topics: 5'-Nucleotidase; Adenocarcinoma; Adenocarcinoma, Scirrhous; Adenosine; Adenosine Deaminase; Age Factors; Aged; Antineoplastic Agents; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Middle Aged; Postoperative Care; Preoperative Care; Thymidine; Thymidine Kinase; Thymidine Phosphorylase | 1990 |
Use of a monoclonal antibody to detect elevated levels of a modified nucleoside, N-[9-(beta-D-ribofuranosyl)purin-6-ylcarbamoyl]-L-threonine, in the urine of breast cancer patients.
Topics: Adenosine; Animals; Antibodies, Monoclonal; Antibody Specificity; Breast Neoplasms; Chromatography, High Pressure Liquid; Creatinine; Female; Humans; Hybridomas; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Radioimmunoassay | 1986 |